VaxInnate Logo
Site Map | Contact Us 
Home About Us Technologies Product Pipeline Media Center
 
 
Developing novel, proprietary vaccines for pandemic and seasonal influenza VaxInnate’s innovative technologies drive development of a new generation of vaccines.
 
 
VaxInnate is developing novel, proprietary vaccines for pandemic and seasonal influenza. Using our proven technology platform, VaxInnate has the potentialto produce potent vaccines for a range of infectious diseases and help meet urgent public health needs.  
BIO International Convention 2008
San Diego, California
June 17-20, 2008
Backgrounders
Technology (PDF)
Corporate (PDF)
Influenza (PDF)
 
 

Recent News [+] View All
09/25/2007 VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine
Company’s First Clinical Trial Studies Vaccine Based on New Vaccine Technology
07/23/2007 VaxInnate Awarded NIH Funding for Collaborative Dengue Fever Vaccine Development
Award based on TLR technology platform’s application in developing vaccines for Flavivirus and other infectious diseases
Contact Us 
Corporate Headquarters
3 Cedar Brook Drive
Cranbury, NJ 08512
609.860.2260
©2008 VaxInnate, Inc.  |  Legal  |  Privacy
A Feinstein Kean Healthcare Site